Pfizer Wins Viagra Patent-Infringement Case

Aug. 15 (Bloomberg) -- Pfizer Inc. won a patent-infringement case that prevents Teva Pharmaceutical Industries Ltd. from marketing a generic version of the impotence drug Viagra until 2019. U.S. District Judge Rebecca Beach Smith in Norfolk, Virginia, ruled Aug. 12 against Petach Tikva, Israel-based Teva, which claimed the patent wasn’t valid and couldn’t be enforced. Shannon Pettypiece reports on Bloomberg Television's "InBusiness with Margaret Brennan." (Source: Bloomberg)